About Devlife Therapeutics Private Limited
Data last updated:
Devlife Therapeutics Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36999MH2020PTC340044. Its GSTIN is 27AAHCD7529D1ZM (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Vaishali Anjaria and Roopa Ramesh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Off No.912 9th Floor J Wing Cts No.1/7 Veer Sawarkar Marg Vikhroli (W), Mumbai, Maharashtra, India – 400079.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.36 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹45.83 Lakh and EBITDA of -₹42.03 Lakh.
As per MCA filings, the company has open charges of ₹10.95 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website devlifecorporation.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressOff No.912 9th Floor J Wing Cts No.1/7 Veer Sawarkar Marg Vikhroli (W), Mumbai, Maharashtra, India – 400079
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Devlife Therapeutics Private Limited
The main business activity of Devlife Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Devlife Therapeutics Private Limited FY 2025 filings available
Devlife Therapeutics Private Limited reported revenue of ₹5.36 Lakh (up 724% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Devlife Therapeutics Private Limited
Revenue rose 724% in the latest year. EBITDA fell 995% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Devlife Therapeutics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹42.03 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹45.83 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Devlife Therapeutics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Devlife Therapeutics are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Devlife Therapeutics Private Limited
Devlife Therapeutics Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Institute of Electro Homeopathy of India | ₹5.46 Lakh (FY 2025) | •••• | •••• | 77.0% | •••• | Kolkata, West Bengal, India |
| Zephyra Enterprise Private Limited | ₹5.44 Lakh (FY 2024) | •••• | •••• | •••• | Nashik, Maharashtra, India | |
| Simplecure Global Private Limited | ₹5.42 Lakh (FY 2025) | •••• | •••• | 148.0% | •••• | Jaipur, Rajasthan, India |
| Jowi Formulations Private Limited | ₹5.4 Lakh (FY 2016) | •••• | •••• | •••• | Hanumangarh, Rajasthan, India | |
| Fitlife Natural Private Limited | ₹5.39 Lakh (FY 2025) | •••• | •••• | 61.0% | •••• | Delhi, India |
| Devlife Therapeutics Private Limited this company | ₹5.36 Lakh (FY 2024) | •••• | •••• | 724.0% | •••• | Mumbai, Maharashtra, India |
| Narshi Pharmaceutical and Surgical Private Limited | ₹5.35 Lakh (FY 2024) | •••• | •••• | -94.0% | •••• | New Delhi, Delhi, India |
| Provido Alserve Private Limited | ₹5.34 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Indore, Madhya Pradesh, India |
| Leefino Pharmaceuticals India Private Limited | ₹5.33 Lakh (FY 2024) | •••• | •••• | •••• | Coimbatore, Tamil Nadu, India | |
| Akhil Farma Limited | ₹5.29 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| G.M.Remedies Private Limited | ₹5.28 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Punjab, India |
Peers are the five companies nearest above and the five nearest below Devlife Therapeutics by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Devlife Therapeutics Private Limited
Devlife Therapeutics Private Limited is audited by BHUTA SHAH & CO LLP for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BHUTA SHAH & CO LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Devlife Therapeutics Private Limited
Devlife Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaishali Anjaria | Director | 27 May 2020 | 6 Years 4 Months | Current |
| Roopa Ramesh Also directs: Devlife Corporation Private Limited | Director | 27 May 2020 | 6 Years 4 Months | Current |
Ownership and Shareholding of Devlife Therapeutics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Devlife Therapeutics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2023 | Hdfc Bank Limited | ₹10.95 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Devlife Therapeutics Private Limited
Devlife Therapeutics Private Limited has a workforce of 0 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Devlife Therapeutics Private Limited
Devlife Therapeutics Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Roopa Ramesh was appointed as Director on 27 May 2020.
Credit Ratings, Litigation & Regulatory Alerts for Devlife Therapeutics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Devlife Therapeutics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Devlife Therapeutics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Devlife Therapeutics Private Limited
Devlife Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCD7529D1ZM | Maharashtra | Active | 15 Dec 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Devlife Therapeutics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devlife Therapeutics Private Limited
Devlife Therapeutics is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 May 2020 (6+ years old) and is registered under CIN U36999MH2020PTC340044.
Devlife Therapeutics reported revenue of ₹5.36 Lakh for FY 2024 (up 724% YoY).
Devlife Therapeutics has 2 current directors:
- Vaishali Anjaria - Director
- Roopa Ramesh - Director
Devlife Therapeutics reported a net loss of ₹45.83 Lakh and EBITDA of -₹42.03 Lakh for FY 2024, as per its filed financial statements.
The GSTIN of Devlife Therapeutics is 27AAHCD7529D1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Devlife Therapeutics is U36999MH2020PTC340044. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Devlife Therapeutics was incorporated on 27 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Devlife Therapeutics by revenue are Institute of Electro Homeopathy of India, Zephyra Enterprise Private Limited, Simplecure Global Private Limited, Jowi Formulations Private Limited, Fitlife Natural Private Limited and 5 more, all in the Pharma industry (Formulations).
Roopa Ramesh was appointed as Director on 27 May 2020. Vaishali Anjaria was appointed as Director on 27 May 2020.
Devlife Therapeutics can be reached through the website devlifecorporation.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Devlife Therapeutics is at Off No.912 9th Floor J Wing Cts No.17 Veer Sawarkar Marg Vikhroli W, Mumbai, Maharashtra, India – 400079.